Loading...

Livzon Pharmaceutical Group Inc.

LVZPF•PNK
Healthcare
Drug Manufacturers - Specialty & Generic
$5.22
$0.00(0.00%)
U.S. Market opens in 13h 57m

Livzon Pharmaceutical Group Inc. (LVZPF) Stock Overview

Explore Livzon Pharmaceutical Group Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap6.1B
P/E Ratio15.65
EPS (TTM)$0.34
ROE0.15%
Fundamental Analysis

AI Price Forecasts

1 Month$5.30
3 Months$5.71
1 Year Target$5.93

LVZPF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Livzon Pharmaceutical Group Inc. (LVZPF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 51.85, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $5.93.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 15.65 and a market capitalization of 6.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
N/A
6-Month Change
N/A
Year-to-Date (YTD) Change
N/A
1-Year Change
52.19%
3-Year Change
104.71%
5-Year Change
41.08%
All-Time (Max) Change
12.99%

Contact Information

https://www.livzon.com.cn
86 75 6813 5888
Headquarters Building, Zhuhai, NaN, 519090

Company Facts

9,067 Employees
IPO DateJun 29, 2018
CountryCN
Actively Trading

Frequently Asked Questions